journal article·2024-07Open access

A Pathologically Friendly Strategy for Determining the Organ‐specific Spatial Tumor Microenvironment Topology in Lung Adenocarcinoma Through the Integration of snRandom‐seq and Imaging Mass Cytometry

Xuqi Sun, Xiao Teng, Chuan Liu, Weihong Tian, Jinlin Cheng, Shuqiang Hao, Yuzhi Jin, Libing Hong, Yongqiang Zheng, Xiaomeng Dai, Linying Wu, Lulu Liu, Xiaodong Teng, Yi Shi, Peng Zhao, Weijia Fang, Yu Shi, Xuanwen Bao

Advanced Science· Volume 11· Issue 26

Abstract

Abstract Heterogeneous organ‐specific responses to immunotherapy exist in lung cancer. Dissecting tumor microenvironment (TME) can provide new insights into the mechanisms of divergent responses, the process of which remains poor, partly due to the challenges associated with single‐cell profiling using formalin‐fixed paraffin‐embedded (FFPE) materials. In this study, single‐cell nuclei RNA sequencing and imaging mass cytometry (IMC) are used to dissect organ‐specific cellular and spatial TME based on FFPE samples from paired primary lung adenocarcinoma (LUAD) and metastases. Single‐cell analyses of 84 294 cells from sequencing and 250 600 cells from IMC reveal divergent organ‐specific immune niches. For sites of LUAD responding well to immunotherapy, including primary LUAD and adrenal gland metastases, a significant enrichment of B, plasma, and T cells is detected. Spatially resolved maps reveal cellular neighborhoods recapitulating functional units of the tumor ecosystem and the spatial proximity of B and CD4+ T cells at immunogenic sites. Various organ‐specific densities of tertiary lymphoid structures are observed. Immunosuppressive sites, including brain and liver metastases, are deposited with collagen I, and T cells at these sites highly express TIM‐3. This study originally deciphers the single‐cell landscape of the organ‐specific TME at both cellular and spatial levels for LUAD, indicating the necessity for organ‐specific treatment approaches.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Single-cell and spatial transcriptomics · Cancer Genomics and Diagnostics · Cancer Immunotherapy and Biomarkers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Oncology The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310003 China

Department of Thoracic Surgery The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310003 China

Changzhou Third People's Hospital Changzhou Medical Center Nanjing Medical University 140 Hanzhong Rd, Gulou Nanjing Jiangsu 210029 China

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310003 China

State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou 510060 China

Department of Respiratory Disease The First Affiliated Hospital College of Medicine Zhejiang University Hangzhou 310003 China

Department of Pathology The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310003 China

Bio‐X Institutes Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders Shanghai Jiao Tong University 1954 Huashan Road Shanghai 200030 China

Funding

National Natural Science Foundation of China · Zhejiang Province Public Welfare Technology Application Research Project · National Key Research and Development Program of China

References (91)

Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.1016/j.lungcan.2014.07.02010.1016/j.lungcan.2014.07.020 ↗
3. 10.1016/j.jtcvs.2017.09.15110.1016/j.jtcvs.2017.09.151 ↗
4. 10.1200/JCO.22.0150310.1200/JCO.22.01503 ↗
5. 10.1001/jama.2019.1105810.1001/jama.2019.11058 ↗
6. 10.1158/1078-0432.CCR-22-299410.1158/1078-0432.CCR-22-2994 ↗
7. 10.1056/NEJMoa180100510.1056/NEJMoa1801005 ↗
8. 10.1016/S0140-6736(18)32409-710.1016/S0140-6736(18)32409-7 ↗
9. 10.1016/S1470-2045(19)30167-610.1016/S1470-2045(19)30167-6 ↗
10. 10.1186/s40425-016-0193-210.1186/s40425-016-0193-2 ↗
11. 10.1186/s12916-022-02315-210.1186/s12916-022-02315-2 ↗
12. 10.1097/CM9.000000000000221710.1097/CM9.0000000000002217 ↗
13. 10.1080/21645515.2020.182377910.1080/21645515.2020.1823779 ↗
14. 10.1007/s00432-019-03104-w10.1007/s00432-019-03104-w ↗
15. 10.1016/j.ccell.2023.02.01610.1016/j.ccell.2023.02.016 ↗
16. 10.1038/s41591-022-01962-510.1038/s41591-022-01962-5 ↗
17. 10.1136/jitc-2022-00532010.1136/jitc-2022-005320 ↗
18. 10.1007/s00428-021-03030-810.1007/s00428-021-03030-8 ↗
19. 10.1016/j.ccell.2022.10.00810.1016/j.ccell.2022.10.008 ↗
20. 10.1038/s43018-021-00292-810.1038/s43018-021-00292-8 ↗
21. 10.1186/s13073-023-01164-910.1186/s13073-023-01164-9 ↗
22. 10.1038/s41586-022-05672-310.1038/s41586-022-05672-3 ↗
23. 10.1016/j.ccell.2021.10.00910.1016/j.ccell.2021.10.009 ↗
24. 10.1016/j.immuni.2019.12.01110.1016/j.immuni.2019.12.011 ↗
25. 10.1002/cncr.3252210.1002/cncr.32522 ↗
26. 10.1007/s00262-018-2239-410.1007/s00262-018-2239-4 ↗
27. 10.1038/s41467-020-16164-110.1038/s41467-020-16164-1 ↗
28. 10.3390/biom1301018510.3390/biom13010185 ↗
29. 10.1038/s41467-023-38409-510.1038/s41467-023-38409-5 ↗
30. 10.1038/s41586-022-05400-x10.1038/s41586-022-05400-x ↗
31. 10.1158/2326-6066.CIR-21-110110.1158/2326-6066.CIR-21-1101 ↗
32. 10.1016/j.cell.2020.07.01310.1016/j.cell.2020.07.013 ↗
33. 10.1158/2159-8290.CD-21-031610.1158/2159-8290.CD-21-0316 ↗
34. 10.1007/s12094-021-02731-510.1007/s12094-021-02731-5 ↗
35. 10.1016/j.humimm.2013.08.26710.1016/j.humimm.2013.08.267 ↗
36. 10.1681/ASN.201808081010.1681/ASN.2018080810 ↗
37. 10.1038/s41467-019-11053-810.1038/s41467-019-11053-8 ↗
38. 10.1126/sciimmunol.abf777710.1126/sciimmunol.abf7777 ↗
39. 10.1038/s41577-019-0257-x10.1038/s41577-019-0257-x ↗
40. 10.1016/j.cell.2016.09.03110.1016/j.cell.2016.09.031 ↗
41. Wu Z. · J. Clin. Invest. · 2022 · 132
42. 10.1002/1521-4141(200108)31:8<2438::AID-IMMU2438>3.0.CO;2-P10.1002/1521-4141(200108)31:8<2438::AID-IMMU2438>3.0.CO;2-P ↗
43. 10.1038/s42255-020-0256-z10.1038/s42255-020-0256-z ↗
44. 10.1038/s41577-021-00537-810.1038/s41577-021-00537-8 ↗
45. 10.1080/25785826.2019.169826110.1080/25785826.2019.1698261 ↗
46. 10.3389/fimmu.2021.71523410.3389/fimmu.2021.715234 ↗
47. 10.1016/j.immuni.2016.08.01710.1016/j.immuni.2016.08.017 ↗
48. 10.3389/fimmu.2023.117987710.3389/fimmu.2023.1179877 ↗
49. 10.1016/j.cels.2018.02.01010.1016/j.cels.2018.02.010 ↗
50. Lim J. S. · 1990
51. 10.5566/ias.v27.p87-9510.5566/ias.v27.p87-95 ↗
52. Nowak M. R. · Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. · 2016 · 2016 · 3989
53. 10.1038/s41598-017-01565-y10.1038/s41598-017-01565-y ↗
54. 10.1038/s41568-021-00366-w10.1038/s41568-021-00366-w ↗
55. 10.1038/s41556-022-01002-x10.1038/s41556-022-01002-x ↗
56. 10.1038/s41568-019-0144-610.1038/s41568-019-0144-6 ↗
57. 10.1016/j.immuni.2019.03.02410.1016/j.immuni.2019.03.024 ↗
58. 10.1016/j.intimp.2021.10764410.1016/j.intimp.2021.107644 ↗
59. 10.4049/jimmunol.167.2.108110.4049/jimmunol.167.2.1081 ↗
60. 10.4049/jimmunol.170.12.589710.4049/jimmunol.170.12.5897 ↗
61. 10.1038/bjc.2013.76810.1038/bjc.2013.768 ↗
62. Liu Z. · Int J Mol Med · 2018 · 42 · 3395
63. 10.1158/2159-8290.CD-14-027510.1158/2159-8290.CD-14-0275 ↗
64. 10.1038/nrc109810.1038/nrc1098 ↗
65. 10.1001/jamanetworkopen.2021.098010.1001/jamanetworkopen.2021.0980 ↗
66. 10.1016/j.cell.2020.07.01710.1016/j.cell.2020.07.017 ↗
67. 10.1158/2159-8290.CD-21-165810.1158/2159-8290.CD-21-1658 ↗
68. 10.1136/jitc-2021-00353410.1136/jitc-2021-003534 ↗
69. 10.1016/j.jtho.2020.10.12810.1016/j.jtho.2020.10.128 ↗
70. 10.1038/s41698-021-00151-w10.1038/s41698-021-00151-w ↗
71. 10.1016/j.ccell.2022.02.00210.1016/j.ccell.2022.02.002 ↗
72. 10.1038/s41586-019-1922-810.1038/s41586-019-1922-8 ↗
73. 10.1158/0008-5472.CAN-17-387610.1158/0008-5472.CAN-17-3876 ↗
74. 10.1126/scitranslmed.aan331110.1126/scitranslmed.aan3311 ↗
75. 10.1080/2162402X.2019.165909310.1080/2162402X.2019.1659093 ↗
76. 10.1038/s43018-021-00232-610.1038/s43018-021-00232-6 ↗
77. 10.1084/jem.2010064310.1084/jem.20100643 ↗
78. 10.1007/s00262-015-1752-y10.1007/s00262-015-1752-y ↗
79. 10.1158/0008-5472.CAN-11-009610.1158/0008-5472.CAN-11-0096 ↗
80. 10.1038/ncomms1050110.1038/ncomms10501 ↗
81. 10.1136/jitc-2020-00091110.1136/jitc-2020-000911 ↗
82. 10.1136/jitc-2021-00388310.1136/jitc-2021-003883 ↗
83. 10.1186/s13059-017-1382-010.1186/s13059-017-1382-0 ↗
84. 10.12688/f1000research.73600.110.12688/f1000research.73600.1 ↗
85. 10.1089/omi.2011.011810.1089/omi.2011.0118 ↗
86. 10.1186/1471-2105-14-710.1186/1471-2105-14-7 ↗
87. 10.1038/s41467-021-21246-910.1038/s41467-021-21246-9 ↗
88. 10.1038/s41467-023-39173-210.1038/s41467-023-39173-2 ↗
89. 10.1002/cyto.a.2432010.1002/cyto.a.24320 ↗
90. 10.1038/s41596-023-00881-010.1038/s41596-023-00881-0 ↗
91. 10.1038/nmeth.439110.1038/nmeth.4391 ↗